Up-regulation of KIF2C has been observed in various cancers, including breast cancer, hepatocellular carcinoma, colorectal cancer, gastric cancer, gliomas, endometrial cancer, and non-small cell lung cancer [21–28]. Here, KIF2C is linked to hepatocellular carcinoma.